Det skal bemærkes, at det med den aktuelt tilgængelige Lamictal 5 mg dispergible tabletter / tyggetabletter styrke ikke er muligt helt nøjagtigt at initiere behandling med lamotrigin ved brug af de anbefalede retningslinjer for dosering hos børn, der vejer under 17 kg.
5 mg dispersible/ chewable tablets – where 2 mg dispersible/ chewable tablets are not marketed and 5 mg dispersible/ chewable tablets are the lowest marketed strength :< It should be noted that with the currently available Lamictal 5 mg dispersible/chewable tablet strength, it is not possible to accurately initiate lamotrigine therapy using the recommended dosing guidelines in paediatric patients weighing less than 17 kg. >